全文获取类型
收费全文 | 92677篇 |
免费 | 7171篇 |
国内免费 | 273篇 |
专业分类
耳鼻咽喉 | 1241篇 |
儿科学 | 2577篇 |
妇产科学 | 1346篇 |
基础医学 | 12727篇 |
口腔科学 | 1030篇 |
临床医学 | 9966篇 |
内科学 | 19897篇 |
皮肤病学 | 1126篇 |
神经病学 | 9216篇 |
特种医学 | 3524篇 |
外国民族医学 | 1篇 |
外科学 | 14407篇 |
综合类 | 1120篇 |
现状与发展 | 1篇 |
一般理论 | 103篇 |
预防医学 | 6870篇 |
眼科学 | 2229篇 |
药学 | 6154篇 |
中国医学 | 132篇 |
肿瘤学 | 6454篇 |
出版年
2023年 | 664篇 |
2022年 | 942篇 |
2021年 | 2591篇 |
2020年 | 1487篇 |
2019年 | 2394篇 |
2018年 | 2726篇 |
2017年 | 1949篇 |
2016年 | 2102篇 |
2015年 | 2428篇 |
2014年 | 3525篇 |
2013年 | 4574篇 |
2012年 | 7159篇 |
2011年 | 7473篇 |
2010年 | 4134篇 |
2009年 | 3588篇 |
2008年 | 6057篇 |
2007年 | 6270篇 |
2006年 | 5839篇 |
2005年 | 5910篇 |
2004年 | 5275篇 |
2003年 | 4855篇 |
2002年 | 4413篇 |
2001年 | 920篇 |
2000年 | 713篇 |
1999年 | 836篇 |
1998年 | 977篇 |
1997年 | 740篇 |
1996年 | 616篇 |
1995年 | 548篇 |
1994年 | 527篇 |
1993年 | 516篇 |
1992年 | 432篇 |
1991年 | 387篇 |
1990年 | 373篇 |
1989年 | 337篇 |
1988年 | 315篇 |
1987年 | 291篇 |
1986年 | 289篇 |
1985年 | 271篇 |
1984年 | 303篇 |
1983年 | 284篇 |
1982年 | 371篇 |
1981年 | 385篇 |
1980年 | 301篇 |
1979年 | 236篇 |
1978年 | 227篇 |
1977年 | 224篇 |
1976年 | 180篇 |
1975年 | 144篇 |
1974年 | 179篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
4.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
5.
Thomas Ruffing Tilmann Rückauer Frederic Bludau Alexander Hofmann Markus Muhm Arnold J Suda 《Injury》2019,50(2):607-612
Introduction
Compression fractures of the cuboid bone in children and adolescents are rare. Fracture morphology, associated lesions, treatment options and long-term outcomes of this very rare injury are published in a few case reports. This study with review of the literature aims to support the understanding of fracture pattern and optimize pathways of decision making.Material and Methods
A retrospective two-center study was performed in a patient cohort treated between 2001 and 2016. All patients aged less than 18 years who sustained a cuboid fracture were included. Age, gender, mechanism of injury, fracture morphology, amount of displacement, associated injuries, and therapy were analyzed. In the follow-up (FU), the AOFAS Midfoot Scale was investigated.Results
Fractures of the cuboid bone were diagnosed in 7 boys and 9 girls. The mean age of the patients was 10 years (range: 2.2–16.1 years). According to the classification of Fenton we detected 11 (69%) type 2, 2 (12%) type 3 and 3 (19%) type 5b fractures. Other fracture types according to Fenton were not observed. All children under 10 years sustained a type 2 fracture. Open reduction and internal fixation was performed in 5 (31%) patients. Bone grafting was not necessary. FU was performed in 14/16 patients on average after 9 years (mean; range: 1.4–16.2 years). The mean AOFAS Midfoot Scale at FU for extra-articular type 2 fractures was 100 points, whereas in intra-articular fractures (Type 3) and fractures associated with mid-tarsal disruption (type 5b) worse results were found (95 and 66 points, accordingly).Conclusion
This rare injury shows inhomogenous morphologies and offers different treatment approaches. Extra-articular Fenton type 2 lesions are the most common type of cuboid fracture in children (69%). A potential loss of length of the lateral column must be considered. In contrast to adults, type 1, 4, and 5a fractures were not found in our cohort of children and adolescents. Lower scores of the AOFAS Midfoot Scale were found with either intra-articular involvement or associated midfoot lesions. 相似文献6.
7.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献8.
9.
10.
William R. C. Knight Cara R. Baker Nyree Griffin Wahyu Wulaningsih Mark Kelly Andrew R. Davies James A. Gossage 《British journal of cancer》2021,124(10):1653
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology 相似文献